Drug Pipeline

Drug Pipeline Market Research Reports

1 . Drug Pipeline Market Research Reports Analysis and Trends

Discovering and bringing new drugs to mainstream commercial market typically takes an average of 10-15 years of research and clinical development efforts. Drug developers need to make sure safe and effective drug available for patient in quick time. The first step is to target the protein available in the patient’s body that is associated with microorganism causing a disease, through tracking of cellular network of proteins an appropriate target for a drug is selected. Through a series of trials, right drug candidate got chosen.
 
According to “NOVARTIS”, bringing a new drug in market takes 14 years of research and cost around USD 2 billion, 10K+ clinical trials out of these, one leads to successful drug development.
Titlesort descending Published Pages Price
1 Phosphatidylinositol 3 Phosphate 5 Kinase (FYVE Finger Containing Phosphoinositide Kinase or Phosphatidylinositol 3 Phosphate 5 Kinase Type III or PIKFYVE or EC 2.7.1.150) - Drugs in Development, 2021 Apr 30 2021 35 USD 3,000.00
1,3 Beta Glucan Synthase (EC 2.4.1.34) - Drugs in Development, 2021 Apr 30 2021 30 USD 3,000.00
16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 Apr 30 2021 85 USD 3,000.00
16S Ribosomal RNA (16S rRNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 71 USD 2,500.00
20s Proteasome - Drugs in Development, 2021 Sep 30 2021 76 USD 3,500.00
20s Proteasome - Pipeline Review, H1 2020 May 30 2020 76 USD 3,500.00
20s Proteasome - Pipeline Review, H2 2018 Oct 23 2018 64 USD 3,500.00
20s Proteasome - Pipeline Review, H2 2019 Dec 27 2019 77 USD 3,500.00
20s Proteasome - Pipeline Review, H2 2020 Nov 30 2020 78 USD 3,500.00
20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Sep 30 2022 89 USD 3,500.00
23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 Apr 30 2021 70 USD 3,000.00
23S Ribosomal RNA (23S rRNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 61 USD 2,500.00
3 Hydroxy 3 Methylglutaryl Coenzyme A Reductase (HMG CoA Reductase or Hydroxymethylglutaryl CoA Reductase or HMGCR or EC 1.1.1.34) - Drugs in Development, 2021 Apr 30 2021 80 USD 3,000.00
3 Hydroxy 3 Methylglutaryl Coenzyme A Reductase (HMG CoA Reductase or Hydroxymethylglutaryl CoA Reductase or HMGCR or EC 1.1.1.34) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 73 USD 2,500.00
3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Drugs In Development, 2021 Jun 30 2021 47 USD 3,500.00
3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Apr 29 2022 45 USD 3,500.00
3-Oxo 5-Alpha Steroid 4 Dehydrogenase 2 (5 Alpha SR2 or Steroid 5 Alpha Reductase 2 or Type II 5 Alpha Reductase or SR Type 2 or SRD5A2 or EC 1.3.1.22) - Drugs in Development, 2021 Apr 30 2021 35 USD 3,000.00
3-Oxo 5-Alpha Steroid 4 Dehydrogenase 2 (5 Alpha SR2 or Steroid 5 Alpha Reductase 2 or Type II 5 Alpha Reductase or SR Type 2 or SRD5A2 or EC 1.3.1.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 37 USD 2,500.00
30S Ribosomal Subunit (30S RNA) - Drugs in Development, 2021 Apr 30 2021 40 USD 3,000.00
30S Ribosomal Subunit (30S RNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 44 USD 2,500.00
3C Like Proteinase (3CL-PRO or 3CLp or EC 3.4.22.) - Drugs in Development, 2021 Apr 30 2021 60 USD 3,000.00
3C Like Proteinase (3CL-PRO or 3CLp or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 79 USD 2,500.00
5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Drugs in Development, 2021 Nov 30 2021 145 USD 3,500.00
5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Pipeline Review, H1 2019 Apr 23 2019 73 USD 3,500.00
5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Pipeline Review, H2 2018 Jul 10 2018 55 USD 3,500.00
5' Nucleotidase - Pipeline Review, H1 2020 Jun 30 2020 109 USD 3,500.00
5' Nucleotidase - Pipeline Review, H2 2019 Aug 30 2019 87 USD 3,500.00
5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR) - Drugs in Development, 2021 Apr 30 2021 40 USD 3,000.00
5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 303 USD 3,500.00
5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1A) - Drugs in Development, 2021 Apr 30 2021 115 USD 3,000.00
5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 119 USD 2,500.00
5-Hydroxytryptamine Receptor 1B (5 HT1B or S12 or Serotonin 1D Beta Receptor or Serotonin Receptor 1B or HTR1B) - Drugs in Development, 2021 Apr 30 2021 55 USD 3,000.00
5-Hydroxytryptamine Receptor 1B (5 HT1B or S12 or Serotonin 1D Beta Receptor or Serotonin Receptor 1B or HTR1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 53 USD 2,500.00
5-Hydroxytryptamine Receptor 1D (5 HT1D or Serotonin 1D Alpha Receptor or Serotonin Receptor 1D or HTR1D) - Drugs in Development, 2021 Apr 30 2021 60 USD 3,000.00
5-Hydroxytryptamine Receptor 1D (5 HT1D or Serotonin 1D Alpha Receptor or Serotonin Receptor 1D or HTR1D) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 54 USD 2,500.00
5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2) - Drugs in Development, 2021 Apr 30 2021 45 USD 3,000.00
5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 200 USD 3,500.00
5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) - Drugs in Development, 2021 Apr 30 2021 170 USD 3,000.00
5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 169 USD 3,500.00
5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - Pipeline Review, H1 2018 Jun 12 2018 50 USD 3,500.00
5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update May 31 2022 45 USD 3,500.00
5-Hydroxytryptamine Receptor 2B - Drugs In Development, 2021 Jun 30 2021 53 USD 3,500.00
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H1 2020 Mar 31 2020 52 USD 3,500.00
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2019 Dec 27 2019 54 USD 3,500.00
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2020 Sep 30 2020 49 USD 3,500.00
5-Hydroxytryptamine Receptor 2C (5 HT2C or 5 Hydroxytryptamine Receptor 1C or Serotonin Receptor 2C or HTR2C) - Drugs in Development, 2021 Apr 30 2021 50 USD 3,000.00
5-Hydroxytryptamine Receptor 2C (5 HT2C or 5 Hydroxytryptamine Receptor 1C or Serotonin Receptor 2C or HTR2C) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 58 USD 2,500.00
5-Hydroxytryptamine Receptor 3 (5HT3 or 5 HT3 Receptor or HTR3) - Drugs in Development, 2021 Apr 30 2021 60 USD 3,000.00
5-Hydroxytryptamine Receptor 3 (5HT3 or 5 HT3 Receptor or HTR3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players May 2 2022 56 USD 2,500.00
5-Hydroxytryptamine Receptor 4 (5 HT4 or Serotonin Receptor 4 or HTR4) - Drugs in Development, 2021 Apr 30 2021 40 USD 3,000.00

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected